Type of post-grafting immunosuppression after non-myeloablative blood cell transplantation may influence risk of delayed haemolysis due to minor ABO incompatibility

British Journal of Haematology

Volumn 116, Issue 2, 2002, Pages 500-501

  Mielcarek, Marco ^a   Maciej Zaucha, J ^a   Sandmaier, Brenda ^a   Maloney, David ^a   Butrynski, James ^a   Maris, Michael ^a   Feinstein, Lyle ^a   Torok Storb, Beverly ^a   Storb, Rainer ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN A; FLUDARABINE; HEMAGGLUTININ; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

ADULT; BLOOD GROUP ABO INCOMPATIBILITY; CELL TRANSPLANTATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; ERYTHROCYTE; ERYTHROCYTE TRANSFUSION; FEMALE; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HEMATOCRIT; HEMATOPOIETIC STEM CELL; HEMOLYSIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IRRADIATION; LETTER; LYMPHOCYTE PROLIFERATION; MALE; MULTIPLE ORGAN FAILURE; MYELOID LEUKEMIA; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; REDUCTION; RISK FACTOR; STEADY STATE; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 0036175020     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2002.03268.x     Document Type: Letter

References (7)

1. Purine metabolism and immunosuppressive effects of mycophenolate mofetil (MMF)
2. Massive immune haemolysis after allogeneic peripheral blood stem cell transplantation with minor ABO incompatibility
3. Mini-allografts: Ongoing trials in humans
4. Hemolysis of transfused group O red blood cells in minor ABO-incompatible unrelated-donor bone marrow transplants in patients receiving cyclosporine without posttransplant methotrexate
5. Mixed chimerism: Preclinical studies and clinical applications
6. Allogeneic unrelated hematopoietic stem cell transplants (HSCT) after conditioning with 2 Gy total body irradiation (TBI), fludarabine (FLU) and a combination of cyclosporine (CSP) and mycophenolate mofetil (MMF) in patients ineligible for conventional transplants
7. Hemolytic complications of hematopoietic cell transplantation